NEW YORK (GenomeWeb) – CareDx said after the close of the market on Tuesday that its revenues in the fourth quarter jumped 36 percent year over year, aided by a one-time payment from Laboratory Corporation ofAmerica. 

The Brisbane, Calif.-based molecular diagnostics firm recorded $8.0 in total revenues for the three months ended Dec. 31, 2014, up from $5.9 million in Q4 2013 and beating the consensus Wall Street estimate of $6.9 million. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Using DNA to sketch crime victims might not be a great idea, the NYTimes says.

Science has its own problem with sexual harassment. What do we do with the research these abusers produce, Wired asks.

Senate Republicans led by Senator Rand Paul (R-KY) are trying to change how the government funds basic research, reports ScienceInsider.

In Science this week: combining genomics and ecology to better understand the effects of natural selection on evolution, and more.